The Clorox Company (NYSE:CLX) Shares Acquired by International Assets Investment Management LLC

International Assets Investment Management LLC grew its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 17,658.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 484,453 shares of the company's stock after purchasing an additional 481,725 shares during the quarter. International Assets Investment Management LLC owned approximately 0.39% of Clorox worth $69,078,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. GHP Investment Advisors Inc. increased its holdings in Clorox by 1.3% in the 4th quarter. GHP Investment Advisors Inc. now owns 5,132 shares of the company's stock worth $720,000 after acquiring an additional 66 shares in the last quarter. Toroso Investments LLC boosted its stake in Clorox by 1.3% during the 1st quarter. Toroso Investments LLC now owns 5,266 shares of the company's stock worth $833,000 after purchasing an additional 68 shares during the last quarter. First National Bank of Mount Dora Trust Investment Services boosted its stake in Clorox by 3.2% during the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company's stock worth $322,000 after purchasing an additional 71 shares during the last quarter. Modera Wealth Management LLC boosted its stake in Clorox by 1.4% during the 3rd quarter. Modera Wealth Management LLC now owns 5,130 shares of the company's stock worth $672,000 after purchasing an additional 71 shares during the last quarter. Finally, Czech National Bank boosted its stake in Clorox by 0.3% during the 4th quarter. Czech National Bank now owns 21,718 shares of the company's stock worth $3,097,000 after purchasing an additional 71 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Down 0.4 %

NYSE CLX traded down $0.61 during trading hours on Friday, reaching $145.94. The company had a trading volume of 738,676 shares, compared to its average volume of 1,180,865. The stock has a 50-day moving average of $151.61 and a 200 day moving average of $141.09. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $178.21. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The stock has a market capitalization of $18.11 billion, a P/E ratio of 231.65, a price-to-earnings-growth ratio of 2.28 and a beta of 0.43.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Thursday, February 1st. The company reported $2.16 EPS for the quarter, beating analysts' consensus estimates of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The company had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.80 billion. During the same quarter in the prior year, the company posted $0.98 earnings per share. Clorox's revenue for the quarter was up 16.0% compared to the same quarter last year. As a group, research analysts anticipate that The Clorox Company will post 5.51 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.29%. Clorox's dividend payout ratio (DPR) is presently 761.92%.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $145.00 to $152.00 and gave the stock a "neutral" rating in a research note on Thursday, January 18th. UBS Group lifted their target price on shares of Clorox from $145.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, February 2nd. Bank of America raised shares of Clorox from an "underperform" rating to a "neutral" rating and lifted their target price for the stock from $120.00 to $150.00 in a research note on Friday, December 15th. Barclays lifted their target price on shares of Clorox from $115.00 to $118.00 and gave the stock an "underweight" rating in a research note on Tuesday, January 16th. Finally, DA Davidson reissued a "neutral" rating and set a $162.00 price target on shares of Clorox in a research report on Monday, February 5th. Four investment analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $148.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.